Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 3Terminated 1

Sponsor Class

INDUSTRY 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Neoplasms 1905Breast Neoplasms 1426Carcinoma, Non-Small-Cell Lung 1179Prostatic Neoplasms 740Colorectal Neoplasms 686Neoplasm Metastasis 624Multiple Myeloma 548Melanoma 529Ovarian Neoplasms 456Lung Neoplasms 447Lymphoma, Non-Hodgkin 385Recurrence 374Lymphoma 374Leukemia, Myeloid, Acute 370Pancreatic Neoplasms 358Carcinoma, Renal Cell 339Carcinoma, Hepatocellular 286Stomach Neoplasms 281Leukemia, Lymphocytic, Chronic, B-Cell 268Lymphoma, Follicular 254Head and Neck Neoplasms 246Glioblastoma 220Leukemia 215Small Cell Lung Carcinoma 183Lymphoma, Large B-Cell, Diffuse 183Squamous Cell Carcinoma of Head and Neck 181Urinary Bladder Neoplasms 175Carcinoma 175Uterine Cervical Neoplasms 174Advanced Solid Tumors 161

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Duodenal Ulcer × Clear all
NCT02153398 2017-01-19

A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases

AstraZeneca

Phase 3 Completed
55 enrolled 31 charts
Gastrointestinal

Duodenal Ulcer, Esophagitis, Peptic, Stomach Ulcer, Zollinger-Ellison Syndrome

NCT01434485 2014-04-16

Nexium Capsules Clinical Experience Investigation

AstraZeneca

Completed
3,691 enrolled
Gastrointestinal

Non-Erosive Reflux Disease, Duodenal Ulcer, Esophagitis, Peptic, Stomach Ulcer, Zollinger-Ellison Syndrome

NCT01435525 2014-04-16

Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation

AstraZeneca

Completed
369 enrolled
Gastrointestinal

Duodenal Ulcer, Stomach Neoplasms, Stomach Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡